Journal: Journal of neural engineering

Article Title: Longitudinal analysis of local field potentials recorded from directional deep brain stimulation lead implants in the subthalamic nucleus

doi: 10.1088/1741-2552/abfc1c

Figure Lengend Snippet: Directional DBS lead implants and experimental timeline. (A) DBS lead with 12 segmented electrodes in a 4 × 3 configuration implanted in the STN of subjects 1 and 2. MRI-T1 images are shown for each subject with segmented reconstructions of the DBS lead (cyan) and STN (red) overlaid on the images. (B) DBS lead with six segmented electrodes in a 2 × 3 configuration was implanted in the STN of subjects 3 and 4. (C) Radial orientation of electrodes relative to the STN (red) for each subject. View is in a plane perpendicular to the oblique DBS lead trajectory. AM-anteromedial; PL-posterolateral. (D) Experimental timeline marks the day of implant and subsequent LFP recordings and impedance spectroscopy measurements.

Article Snippet: We also thank Abbott Neuromodulation (Filippo Agnesi) and Heraeus Medical Components (Mark Hjelle, Robert Cass, Ben Probiel, Mitch Lark, Paul Noffke, Cullen Boyd, David Ohmann, John Warling, Vu Tran, and Alan Carlson) for their collaborations on developing the scaled-down directional DBS leads.

Techniques: Impedance Spectroscopy

Journal: Frontiers in Medical Technology

Article Title: Technological Improvement Rates and Evolution of Energy-Based Therapeutics

doi: 10.3389/fmedt.2021.714140

Figure Lengend Snippet: Illustrations of exemplar technologies in energy-based therapeutic domains: (A) electrical stimulation of vagus nerve ; (B) transcranial magnetic stimulation of brain ; (C) microwave hyperthermia of brain ; (D) optical stimulation of cochlea with near infrared light ; (E) brain stimulation with focused ultrasound (FUS) .

Article Snippet: Patent US4285347 (node 20) from Cordis Corporation on directional neural lead for spinal stimulation was the first one to make the linkage in the 1980s.

Techniques:

Journal: Frontiers in Medical Technology

Article Title: Technological Improvement Rates and Evolution of Energy-Based Therapeutics

doi: 10.3389/fmedt.2021.714140

Figure Lengend Snippet: Heat map of percentage of common patents between domains. A diagonal cell shows the percentage of patents in a focal domain (e.g., 97.3% for optical stimulation in the fourth row) that are not common with any of the other domains. The off-diagonal cell indicates the percentage of patents in a focal domain common with another domain (e.g., 0.6% for optical stimulation with Microwave/RF stimulation).

Article Snippet: Patent US4285347 (node 20) from Cordis Corporation on directional neural lead for spinal stimulation was the first one to make the linkage in the 1980s.

Techniques:

Journal: Frontiers in Medical Technology

Article Title: Technological Improvement Rates and Evolution of Energy-Based Therapeutics

doi: 10.3389/fmedt.2021.714140

Figure Lengend Snippet: Main paths for the electrical therapeutic domain. E1: A patent cluster for cardiac stimulation for pacing and defibrillation (red box); E2: A patent cluster for neurostimulation (purple box). The blue box shows a subcluster for MRI-compatible leads and electrodes. The patents inside the E1, which are highlighted with red concentric circles, are neuromodulation patents. The table presents details of each patent in the main paths. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.

Article Snippet: Patent US4285347 (node 20) from Cordis Corporation on directional neural lead for spinal stimulation was the first one to make the linkage in the 1980s.

Techniques:

Journal: Frontiers in Medical Technology

Article Title: Technological Improvement Rates and Evolution of Energy-Based Therapeutics

doi: 10.3389/fmedt.2021.714140

Figure Lengend Snippet: Main paths for the magnetic therapeutic domain. MG1: A patent cluster for stimulation of tissue/bone growth; and MG2: a patent cluster for transcranial brain stimulation. The table presents details of each patent in the main paths. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.

Article Snippet: Patent US4285347 (node 20) from Cordis Corporation on directional neural lead for spinal stimulation was the first one to make the linkage in the 1980s.

Techniques:

Journal: Frontiers in Medical Technology

Article Title: Technological Improvement Rates and Evolution of Energy-Based Therapeutics

doi: 10.3389/fmedt.2021.714140

Figure Lengend Snippet: Main paths for the optical therapeutic domain. OP1: A patent cluster for photochemical stimulation of tissue; OP2: a patent cluster for stimulation of nerves of using light; and OP3: a patent cluster for skin treatment using a laser. The table presents details of each patent in the main paths. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.

Article Snippet: Patent US4285347 (node 20) from Cordis Corporation on directional neural lead for spinal stimulation was the first one to make the linkage in the 1980s.

Techniques:

Journal: Frontiers in Medical Technology

Article Title: Technological Improvement Rates and Evolution of Energy-Based Therapeutics

doi: 10.3389/fmedt.2021.714140

Figure Lengend Snippet: Main paths for the ultrasound therapeutic domain. US1: A patent cluster for tissue lesioning; US2: bone growth technologies; US3: a patent cluster for wound-healing technologies; and US4: a patent cluster for nerve-stimulation technologies. The table presents node numbers with corresponding patents and their description. High-persistence patents are shown as bigger yellow circles, whereas the low-persistence patents are shown as smaller gray circles.

Article Snippet: Patent US4285347 (node 20) from Cordis Corporation on directional neural lead for spinal stimulation was the first one to make the linkage in the 1980s.

Techniques:

Journal: Cardiovascular Digital Health Journal

Article Title: Implementation and early experience of a pediatric electrophysiology telehealth program

doi: 10.1016/j.cvdhj.2021.12.004

Figure Lengend Snippet: Testing and downstream work relative value units generated

Article Snippet: There were 17 tests (10%) completed during the TH visit, including 4 single-lead ECGs (24%) using a direct-to-consumer ECG device (either Kardia Monitor by AliveCor or Apple Watch by Apple), 7 wound check photographs (41%), and 6 CIED remote device transmissions (35%).

Techniques: Generated, Transmission Assay

Journal: medRxiv

Article Title: Postoperative Determination of Directional Deep Brain Stimulation (DBS) Lead Orientation Using Rotational Fluoroscopy: Interobserver Agreement and Comparison with CT-Based Software

doi: 10.1101/2025.08.24.25334315

Figure Lengend Snippet: Polar histograms and distribution plots of directional DBS lead orientations estimated via the Iron Sight method from postoperative rotational fluoroscopy at Jaslok Hospital, Mumbai (2022-2024). A-D: Observer-specific orientation estimates (n=70 leads). E: Histogram of interobserver angular differences with Gaussian Fit. F: Polar histogram of interobserver angular differences fitted with von Mises distribution.

Article Snippet: Participants were recruited from among patients who underwent DBS surgery with directional leads (Vercise CartesiaTM, Boston Scientific) between May 1, 2022, and December 31, 2024.

Techniques:

Journal: medRxiv

Article Title: Postoperative Determination of Directional Deep Brain Stimulation (DBS) Lead Orientation Using Rotational Fluoroscopy: Interobserver Agreement and Comparison with CT-Based Software

doi: 10.1101/2025.08.24.25334315

Figure Lengend Snippet: Agreement between rotational fluoroscopy (Iron Sight method) and Brainlab Elements™ software in determining orientation of directional DBS leads (67 leads, Jaslok Hospital, Mumbai, 2022-2024). A: Bland-Altman plot. B: Preiss-Fisher test for agreement. C: ICC (3,1) for inter-method reliability.

Article Snippet: Participants were recruited from among patients who underwent DBS surgery with directional leads (Vercise CartesiaTM, Boston Scientific) between May 1, 2022, and December 31, 2024.

Techniques: Software